StockWatch
·

Oxygenta Pharmaceutical Ltd Q4 FY25 Results

OXYGENTAPHQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue49.4749.0%
Total Income49.5247.0%
Expenditure53.0437.2%
PBT-3.8023.4%
Net Profit-2.1545.2%
OPM-3.95%15.76pp
NPM-4.35%7.31pp
EPS0.60156.1%
View full financials

Informational and educational content only. Not investment advice.